Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential.
D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D002375:Catalepsy / Q000139:chemically induced; D005475:Flupenthixol / Q000037:antagonists & inhibitors; D006220:Haloperidol / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012601:Scopolamine / Q000494:pharmacology*; D013239:Stereotyped Behavior / Q000187:drug effects
D014150:Antipsychotic Agents; D012601:Scopolamine; D005475:Flupenthixol; D006220:Haloperidol